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doi:10.1Objective: Owing to the complexity of the underlying lesions, Barlow disease remains a challenge for surgeons
performing mitral valve repair. We aimed to assess whether our most recent results involving several surgeons
were comparable with those of a previous experience in which mitral valve repair was performed by a more lim-
ited group of surgeons.
Methods: From September 2000 to January 2007, 200 patients with Barlow disease (135 men and 65 women;
mean age, 56 13 years) were referred to our institution for surgical treatment of their mitral regurgitation. We
retrospectively analysed the mitral lesions characteristics, the surgical techniques used, and clinical outcomes.
Follow-up echocardiograms were biannually reviewed.
Results: Lesions comprised annular dilatation, excess tissue, and leaflet prolapse in all cases. The most frequent
prolapsed segments were P2 (88.5%; n¼ 177) and A2 (55.5%; n¼ 111). Annular calcifications and restrictive
valvular motion were associated in 20% (n ¼ 40). Repair was feasible in 94.7% (n ¼ 179/189) of non-redo in-
terventions. Immediate postoperative echocardiography showed residual mitral regurgitation greater than 1þin 6
cases; these patients were all reoperated on within the next months. Operativemortality was 1.5% (n¼ 3). Mean
follow-up was 77.5  25.6 months. At 8 years postoperatively, overall survival was 88.6%  3.1%, freedom
from reintervention was 95.3%  1.7%, and freedom from late recurrent moderate mitral regurgitation
(>2þ) was 90.2%  3.1%
Conclusions: Provided that the fundamental principles of mitral valve reconstruction are respected, the surgical
techniques are highly reproducible with good long-term results, similar to those published during the pioneering
phase of this surgery. (J Thorac Cardiovasc Surg 2012;143:S17-20)Barlow disease or billowing mitral valve (MV) syndrome
accounts for approximately 30% of the patients undergo-
ing MV repair for degenerative disease.1 Multiple confus-
ing terminologies have been used to describe it in the
literature, including floppy valve, myxomatous valve, and
MV prolapse, whereas leaflet prolapse should refer only
to a nonspecific dysfunction in which the free edge of
the leaflet overrides the annular plane. Within the group
of degenerative diseases, 2 distinctive entities should be
distinguished: fibroelastic deficiency and Barlow disease.2
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The Journal of Thoracic and Carvalve structure, and microscopic lesions. As opposed to fi-
broelastic deficiency, Barlow disease is characterized by
excess of thickened leaflet as a result of myxoid degener-
ation.3 It is typically observed in a patient under 60 years
of age with complex MV lesions including severe annular
dilatation, generalized excess of tissue, leaflet billowing,
and multiple sites of leaflet prolapse.2 In forme fruste of
Barlow disease, the excess of tissue involves only a part
of the valve. Microscopically, myxoid infiltrations are as-
sociated with alterations predominantly involving collagen
fibers rather than elastic fibers.1 Nevertheless, the distinc-
tion between Barlow disease and fibroelastic deficiency
is seldom made in the literature and the results of complex
MV repair in Barlow disease are still not very widely
known.
The long-term superiority of MV repair over replacement
in severe mitral regurgitation (MR) has been well estab-
lished.4,5 A better understanding of the mechanisms of MR
and improvements in echocardiography have both allowed
surgeons to performmore complexMV reconstruction.6 Still,
among degenerative MV diseases, Barlow disease remains
a challenge for surgeons.
Following the evolution of Carpentier’s techniques over
the years, our institution has been implicated in understand-
ing and treating Barlow disease by reconstructive valvediovascular Surgery c Volume 143, Number 4S S17
Mitral Valve Prolapse Jouan et alS1Abbreviations and Acronyms
LCOS ¼ low cardiac output syndrome
MR ¼ mitral regurgitation
MV ¼ mitral valve
SAM ¼ systolic anterior motion
TEE ¼ transesophageal echocardiographysurgery. We report our latest results with MV repair in Bar-
low disease with a critical analysis of the surgical problems
that have been encountered and report postoperative mid-
term results.
PATIENTS AND METHODS
Between September 2000 and January 2007, a total of 453 patients un-
derwent MV surgery at our institution for degenerative disease; Barlow
disease was identified in 200 cases.
The diagnosis of Barlow disease was based on the patient’s medical his-
tory and preoperative 2-dimensional echocardiography showing dilatation
of the annulus, excess valvular tissue with billowing leaflets, and leaflet
thickening. The diagnosis was confirmed, at the time of surgery, by gross
examination and by histologic examination of the resected tissue specimen,
attesting global myxomatous proliferation. Formes frustes with excess tis-
sue localized onto several segments of the posterior leaflet and commis-
sures were also included.
There were 135 men and 65 women with a mean age of 56.0  13.4
years. Fifty-one (25.5%) patients were in New York Heart Association
class III or IV and 25 (12.5%) had preoperative atrial fibrillation.
Preoperative 2-dimensional echocardiography showed an ejection frac-
tion of less than 50% in 26 (13%) patients and an end-systolic left ventricle
diameter over 45 mm in 36 (18%) patients.
Nine (4.5%) patients had deterioration of a previous MV repair per-
formed in another institution. Twenty-seven (13.5%) patients needed a con-
comitant procedure: Cox maze, tricuspid valve annuloplasty, coronary
artery bypass, or aortic valve replacement.
All procedures were performed in the same institution by 8 surgeons
having different levels of expertise in MV repair but using Carpentier’s
techniques.
Postoperative transesophageal echocardiography (TEE) was performed
in all cases before chest closure. A predischarge transthoracic echocardio-
gram was also performed to confirm the results of the surgical procedure.
Follow-up
The mean follow-up was 77.5  25.6 months. Follow-up was complete
in 97% of the cases. It was done by contact with each patient and the re-
ferring cardiologist. Late echocardiograms were obtained from the refer-
ring cardiologists and reviewed every 2 years.
Statistical Analysis
Data analyses were performedwith SPSS software (SPSS, Inc, Chicago,
Ill) and SAS software (SAS Institute, Inc, Cary, NC). Descriptive statistics
were expressed as mean standard deviation for continuous variables and
percentage and/or frequencies for categorical variables. Estimates for
long-term survival and freedom from adverse events were made by the
Kaplan-Meier method.
Preoperative patient variables were entered into a binary logistic regres-
sion analysis to highlight independent predictors of immediate adverse out-
comes. The appropriateness of tested variables was first determined by
univariate analysis using a c2 or Fisher exact test for categorical data and
the Student t test for continuous data. Finally, the Kaplan-Meier method8 The Journal of Thoracic and Cardiovascular Surgwas used to determine univariate predictors of late adverse outcomes. Ev-
ery variable with a P value<.2 was entered into a Cox regression multivar-
iate model to identify independent multivariate predictors.RESULTS
Intraoperative functional MV analysis revealed a dilated
annulus and a prolapse (type II) in all cases. The site of mi-
tral prolapse is detailed in Table 1. A restrictive leaflet mo-
tion (type IIIa) was associated with leaflet prolapse in
7 (3.5%) patients and was the consequence of the fibrous
scar of a previous MV repair. Calcification of the annulus
was present in 40 (20%) patients.
Repair was feasible in 182 (91%) patients. In the remain-
ing 18 patients, theMVwas judged unsuitable for repair and
was therefore replaced. Seven of these patients had been
previously operated on for their MV disease. Thus, the fea-
sibility of MV reconstruction in initial surgery was 94.7%.
Mean bypass time was 147  64 minutes. The surgical
reconstructive techniques used at each level of the MV ap-
paratus are summarized in Table 1. Quadrangular resection
of the posterior leaflet was performed without sliding plasty
in 54 (29.7%) patients and was associated with a sliding
plasty in 127 (69.8%). Commissural or paracommissural
prolapse was addressed by localized edge-to-edge tech-
nique, also called commissuroplasty, in 10 (5.5%) patients.
The prosthetic rings used in MV repairs were 34 mm in 54
(29.7%) patients, 36 mm in 84 (46.1%), 38 mm in 24
(13.2%), and 40 mm in 20 (11%) patients. After the pa-
tients had been weaned from bypass and had reached opti-
mal hemodynamic conditions, intraoperative TEE showed
residual MR (>1þ) in 6 patients. This problem was ad-
dressed by MV replacement in 1 patient, insertion of
a more adapted ring in 1 patient, a complementary MV re-
pair procedure in 2 patients, and abstention in 2 patients.
A systolic anterior motion (SAM) of the anterior leaflet
was detected in 6 patients and was resolved by increased
left ventricular filling in 3 patients; in the remaining 3, the
problem was fixed by insertion of a larger prosthetic ring,
reduction of the height of the posterior leaflet, and MV
replacement.
In-hospital mortality was 1.5% (n ¼ 3). Complications
during intensive care unit stay were as follows: low cardiac
output syndrome (LCOS) in 25 (12.5%) patients, pro-
longed intubation over 48 hours and/or acute respiratory
distress syndrome in 10 (5%) patients, and postoperative
hemorrhage requiring surgical reintervention in 3 (1.5%)
patients.
LCOS was defined by the association of the following
criteria: (1) arterial systolic blood pressure less than 90
mm Hg, (2) central venous pressure greater than 12 mm
Hg, (3) globally hypokinetic left ventricle (ejection fraction
<50%) on intraoperative TEE (after weaning from cardio-
pulmonary bypass) or on postoperative transthoracic echo-
cardiography, and (4) need for inotropic support for at leastery c April 2012
TABLE 1. Sites of mitral leaflet prolapse and surgical techniques used
for repair according to the level of the lesion
Sites of leaflet prolapse Value (%) No. of patients
Posterior leaflet
P1 28 56
P2 88.5 177
P3 40 80
Anterior leaflet
A1 17 34
A2 55.5 111
A3 37.5 75
Commissures
Posterior 20.5 41
Anterior 6.5 13
Level Type Value (%) No. of patients
Annulus Ring annuloplasty 100 182
Decalcification 8.8 16
Posterior leaflet Resection 29.7 54
Sliding plasty 69.8 127
Chordal transfer 7.7 14
Anterior leaflet Resection 3.8 7
Chordal transfer 25.3 46
Neochordae 4.4 8
Commissure Edge-to-edge 5.5 10
Papillary muscle PM shortening 25.3 46
PM sliding plasty 10.4 19
Chordal shortening 4.4 8
PM, Papillary muscle.
Jouan et al Mitral Valve Prolapse6 hours or for mechanical support (intra-aortic balloon
counterpulsation).
By univariate analysis, predictors of operative mortality
were chronic obstructive pulmonary disease (P ¼ .005)
and MV replacement (P ¼ .004). Predictors of LCOS
were preoperative left ventricular ejection fraction less
than 60% (P ¼ .03) and total bypass time (P<.001).
By multivariate analysis, chronic obstructive pulmonary
disease and total bypass time were independent predictors
of operative mortality and LCOS, respectively.
At 8 years postoperatively, overall survival was 88.6%
 3.1% and freedom from cardiac death was 93.6% 
2.3% (Figure 1, A). Predictive factors of late cardiac death
were MV replacement (P ¼ .003), redo surgery (P ¼
.006), LCOS (P ¼ .002), and preoperative New York Heart
Association class III/IV (P ¼ .001). By multivariate anal-
ysis, LCOS and MV replacement were independent pre-
dictors of late cardiac death (P ¼ .032 and P ¼ .003,
respectively).
Freedom from reintervention was 95.3%  1.7% at 8
years. The 7 patients who required reoperation at the time
of follow-up were distributed as follows: (1) Three patients
had a new chordal rupture at 1, 10, and 42months; 2 of these
patients underwent MV rerepair and 1 patient underwent
MV replacement. (2) Two patients had more than mildThe Journal of Thoracic and Carresidual MR on postoperative TEE; they eventually needed
MV replacement within the first month. (3) One patient had
acute endocarditis develop on a bioprosthesis at 2 months.
(4) One patient had a fibrous restrictive posterior leaflet
scar develop and had an MV replacement at 11 months.
Freedom from late moderate recurrent MR (>2þ) was
90.2%  3.1% at 8 years (Figure 1, B).
DISCUSSION
MV reconstruction in Barlow disease respecting the fun-
damental principles of Carpentier’s techniques provided
a high proportion of repair feasibility and good long-term
results. These results of MV obtained by 8 surgeons were
similar to those of the pioneering phase ofMV repair for de-
generative disease of our institution, which was essentially
based on the experience of a more limited number of sur-
geons, thereby reflecting the high reproducibility of the sur-
gical techniques used.4
One of the most challenging aspects of surgical repair in
Barlow disease is obviously the presence of an anterior
leaflet billowing, frequently associated with prolapse.
Extensive billowing hampers the surgical segmental MV
analysis. Preoperative TEE plays a major role in pointing
out the prolapsed areas. Nevertheless, anterior leaflet pro-
lapse clearly jeopardizes the results of MV repair.7 Our ap-
proach for this lesion has evolved during the past decade.
Chordal shortening should no longer be used, as advocated
by others,8 and papillary muscle plasty is currently pre-
ferred to chordal transposition in the setting of large pro-
lapsed areas without chordal rupture. These technical
evolutions, as noted by others, have improved the results
of MV reconstruction in Barlow disease.9 ‘‘Edge-to-
edge’’ repair, even though immediately satisfactory, pro-
duces uncertain midterm results and some degree of valve
stenosis,10 which could be questionable for patients under
the age of 60 years.
Preoperative TEE is also of utmost importance in the pre-
vention of SAM. It allowsmeasurements of the height of the
leaflets and calculation of the aorta–mitral angle and esti-
mates the volume of the left outflow tract. This information
helps in predicting the risk of postoperative SAM and
guides the surgeon in the MV reconstruction. Our policy
is to perform a sliding plasty when the height of the poste-
rior leaflet is greater than 15 mm or greater than one third
the height of the anterior leaflet. Careful measurement of
the height of the anterior leaflet and subsequent ring selec-
tion significantly reduced the risk of SAM.11 In our series,
more than 20% of patients required a prosthetic ring of
38 or 40 mm. Such a policy has permitted us to reduce
the number of cases of SAM in the past decade of our expe-
rience, and in the present series only 3 cases of significant
SAM remained after adequate left ventricular filling.
Although not frequently reported in the literature, LCOS
was the most frequent complication encountered in thisdiovascular Surgery c Volume 143, Number 4S S19
FIGURE 1. Kaplan-Meier survival curves. A, Global survival and freedom from cardiac death of the whole population (n ¼ 200). B, Freedom from re-
current moderate (>2þ) mitral regurgitation (MR) of patients undergoing mitral valve repair (n ¼ 182).
Mitral Valve Prolapse Jouan et alstudy. Preoperative left ventricular dysfunction and com-
plex MV lesions requiring longer bypass times were both
predictive factors of LCOS. Owing to the specific character-
istics of patients with Barlow disease, other frequently re-
ported predictive factors of LCOS, such as age and
female gender, were not identified in this series. Interest-
ingly, LCOS was predictive of rather than an immediate
cause of cardiac death. This argues for an optimal intraoper-
ative management of patients with risk factors of LCOS.
Valve replacement and coronary artery disease were the
other 2 factors influencing late mortality. This finding is
consistent with the common idea that MV repair has a better
long-term prognosis than MV replacement, even in the set-
ting of complex valve lesions.7,9 It also emphasizes the
importance of referring patients with Barlow disease to
centers experienced in MV repair, as suggested by the
recent guidelines of the American Heart Association and
American College of Cardiology.CONCLUSIONS
Barlow disease is a specific degenerative process leading
to extensive lesions of the MV. Despite its complexity, MV
reconstruction is most often possible and should be pre-
ferred in this young population. The long-term results are
good, provided that surgeons use reproducible techniques
and do not accept more than mild MR on the postoperative
control echocardiogram. However, owing to the possible
progression of this degenerative process, close follow-up
has to be achieved after surgery.S20 The Journal of Thoracic and Cardiovascular SurgReferences
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